Analysts Set Compass Therapeutics, Inc. (NASDAQ:CMPX) Price Target at $11.38
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year target price among […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year target price among […]
